298 related articles for article (PubMed ID: 22072014)
1. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
[TBL] [Abstract][Full Text] [Related]
3. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
5. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort.
Zhang W; Feng S; Yan S; Zhao Y; Li M; Sun J; Zhang FC; Cui Q; Dong Y
Rheumatology (Oxford); 2010 Mar; 49(3):571-7. PubMed ID: 20040528
[TBL] [Abstract][Full Text] [Related]
6. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
7. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
8. Primary Sjogren's syndrome and the risk of acute pancreatitis: a nationwide cohort study.
Chang CC; Chang YS; Wang SH; Lin SY; Chen YH; Chen JH
BMJ Open; 2017 Aug; 7(8):e014807. PubMed ID: 28801391
[TBL] [Abstract][Full Text] [Related]
9. Risk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort Study.
Chen JY; Wang LK; Feng PH; Chu CC; Cheng TJ; Weng SF; Wu SZ; Lu TH; Chang CY
PLoS One; 2015; 10(8):e0134930. PubMed ID: 26305359
[TBL] [Abstract][Full Text] [Related]
10. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.
Tseng CC; Yen JH; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Chang SJ
Autoimmunity; 2015; 48(7):438-44. PubMed ID: 25980318
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003.
Alamanos Y; Tsifetaki N; Voulgari PV; Venetsanopoulou AI; Siozos C; Drosos AA
Rheumatology (Oxford); 2006 Feb; 45(2):187-91. PubMed ID: 16332955
[TBL] [Abstract][Full Text] [Related]
13. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
Ahn JK; Hwang J; Seo GH
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
[TBL] [Abstract][Full Text] [Related]
14. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
16. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
17. Incidence and mortality of treated primary Sjogren's syndrome in Taiwan: a population-based study.
Weng MY; Huang YT; Liu MF; Lu TH
J Rheumatol; 2011 Apr; 38(4):706-8. PubMed ID: 21239759
[TBL] [Abstract][Full Text] [Related]
18. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y; Yang Z; Qin B; Zhong R
Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
[TBL] [Abstract][Full Text] [Related]
19. Incidence of primary Sjogren's syndrome in Slovenia.
Plesivcnik Novljan M; Rozman B; Hocevar A; Grmek M; Kveder T; Tomsic M
Ann Rheum Dis; 2004 Jul; 63(7):874-6. PubMed ID: 15194588
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
